Philips Healthcare extends contract for image-guided oncology

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 11
Volume 17
Issue 11

Philips Healthcare will continue its relationship with the University Medical Center (UMC) in Utrecht, the Netherlands to develop new imaging products for the diagnosis, monitoring, and treatment of cancer. The partners will focus on image-guided oncology interventions to direct translational research into clinical applications.

Philips Healthcare extends contract for image-guided oncology

Philips Healthcare will continue its relationship with the University Medical Center (UMC) in Utrecht, the Netherlands to develop new imaging products for the diagnosis, monitoring, and treatment of cancer. The partners will focus on image-guided oncology interventions to direct translational research into clinical applications.

Xoft demonstrates nonisotope based therapy

Early experience demonstrates that an electronic brachytherapy technique for intracavitary radiation is a viable option for adjuvant therapy for early-stage breast cancer, according to a poster at the ASCO Breast Cancer Symposium 2008. The product, Axxent, developed and marketed by Xoft, delivers therapy electronically, without the use of radioactive isotopes.

First Novalis Tx system installed in Oregon

The department of radiation medicine at Oregon Health & Science University in Portland now offers image-guided stereotactic body radiation therapy and radiosurgery using Novalis Tx technology from Varian Medical Systems and BrainLAB. To date, Martin Fuss, MD, director of the image-guided radiation therapy program, and colleagues have used the software to treat over 30 patients, none of whom qualifi ed for open surgery or conventional RT for brain, spine, lung, and liver cancers.

New CPT code given to Calypso tracking device

The American Medical Association has assigned a new CPT code (0197T) to Calypso Medical’s 4D Localization System. The AMA has identified intrafraction tracking as a new radiation therapy procedure.

The code will go into effect on January 1, 2009. Also, CMS recommends using HCPCS codes A4648 (freestanding centers) and C1879 (hospital outpatient) with Calypso’s Beacon.

Recent Videos
Using the monitoring of symptoms and quality of life platform may provide a quick and efficient system for patients to submit outcome data.
2 experts are featured in this series.
With many treatments emerging in the EGFR-mutated lung cancer landscape, sequencing therapy has emerged as a key consideration for these patients.
Although a greater risk of CNS relapse may emerge with immunotherapy-based backbones, toxicities associated with chemotherapy are avoided.
Current FDA expectations may allow patients to return to their community physicians at 2 weeks after administration of anitocabtagene autoleucel.
Based on its mechanism of action, anito-cel may cause fewer instances of cytokine release syndrome and delayed toxicities vs other therapies.
2 experts are featured in this series.
Related Content